Analysis of the standardized mortality rates due to skin and subcutaneous tissue diseases in 2023 reveals notable trends across countries. South Africa displays the highest rates, with Argentina and Brazil following. In Europe, Slovakia led in mortality, while figures were significantly lower in Nordic and Western European nations. Over the past two years, Portugal, Iceland, and Estonia exhibited substantial increases in mortality rates, while Slovenia, Hungary, and Israel showed declines. Over five years, the growth has been variant, highlighting targeted health strategies.
Future trends to monitor include:
- Possible impacts of healthcare enhancements in low-performing regions.
- Influence of changing environmental factors on disease prevalence.
- Continued analysis of demographic shifts impacting health statistics.
Top countries in Skin and Subcutaneous Tissue Diseases Mortality by Country
| # | 10 Countries | Units (Female Deaths) Per Hundred Thousand Women, Standardised Rates | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 South Africa | 10.5 | 2023 | +1.94% | +1.6% | View data |
| 2 | 2 Argentina | 9.7 | 2023 | +5.43% | +1.51% | View data |
| 3 | 3 Brazil | 7.5 | 2023 | +4.17% | +6.4% | View data |
| 4 | 4 Colombia | 6.5 | 2023 | 0% | +4.97% | View data |
| 5 | 5 Peru | 6.2 | 2023 | +6.9% | +1.7% | View data |
| 6 | 6 Chile | 5.9 | 2023 | +1.72% | -0.66% | View data |
| 7 | 7 Slovakia | 4.6 | 2023 | +2.22% | +1.36% | View data |
| 8 | 8 Costa Rica | 4.3 | 2023 | +10.26% | -0.46% | View data |
| 9 | 9 Israel | 4 | 2023 | 0% | -2.76% | View data |
| 10 | 10 Latvia | 3.4 | 2023 | +3.03% | -0.58% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
